Evidence map›Paper›PMID 40682360›Full record

ArticleJournal of cosmetic dermatology2025

A New Predictive Model for Tattoo Removal: Leveraging Patient and Tattoo Characteristics.

Candice Menozzi-Smarrito, Nicolas Pineau

Abstract read
In one paragraph

Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Candice Menozzi-SmarritoRIVIERAClinic, Switzerland.
Nicolas Pineaudatainsightswiss, Lausanne, Switzerland.ORCID https://orcid.org/0000-0003-2872-4572

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe objective of this research was to investigate key parameters impacting the process of tattoo removal and to propose a new predictive model for estimating the number of sessions necessary for the complete removal of black tattoos with a picosecond laser.

methodsThis prospective study involved 116 patients aged 18-62 years who visited our center between January 2020 and June 2024 for the full treatment of black tattoos. Data were collected about patient (age, gender, and phototype), tattoo specifics (age, size, location, ink density, country/region where the tattoo was created, if it was realized by an amateur or a professional tattoo artist, tattoo settings) and the total number of laser treatments. Treatments were performed with a Picosure laser (Cynosure, USA) at 755 nm using fluences of 0.69-6.37 J/cm RESULTS AND

conclusionANOVA results revealed that ink density had the most significant impact on laser tattoo removal, followed by tattoo location, age, and design technique (dots, lines, or both). Country/region of origin and whether the tattoo was amateur or professional had a marginal effect, whereas design type (drawing or letters), patient age, skin type, gender, and tattoo size showed no significant influence. Based on these findings, we developed a new efficient predictive tool to estimate the number of picosecond laser sessions required for complete black tattoo removal. The Smarrito-Pineau (SP) model could be readily implemented since variables are easily assessable. It was possible to provide personalized treatment plans and enhance patient satisfaction by offering more accurate treatment timelines.

Indexed as

Lasers, Solid-StateLow-Level Light TherapyTattooingAdolescentAdultFemaleHumansInkMaleMiddle AgedProspective StudiesTattoo RemovalYoung Adultblack tattoolaserpicosecondpredictive modeltattoo removal

Identifiers

PMID40682360
PMCPMC12274964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.